comparemela.com

Page 13 - Chris Hollowood News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Acquisition set to take ocular therapies to patients

Gyroscope Therapeutics Holdings, a portfolio company of life sciences investment trust Syncona Ltd, has been acquired by Novartis for up to $1. Click to read more.

United kingdomChris hollowoodSyncona investment managementSyncona ltdGyroscope therapeutics holdingsChief investment officerSyncona investment management limited

Investegate |Syncona Limited Announcements | Syncona Limited: Gyroscope to be acquired for up to $1 5 billion

Investegate announcements from Syncona Limited, Gyroscope to be acquired for up to $1.5 billion

United kingdomChris hollowoodBen atwellMeagher flomFergus wittTim stamperGoldman sachs internationalSyncona investment managementSyncona ltd is andrew cossarSyncona ltdGyroscope therapeutics holdingsGyroscope therapeuticsChief investment officerSyncona investment management limitedFinancial adviserLegal adviser

Caspian Sunrise PLC climbs on positive production and financial update

A look at the major movers on the London market on Wednesday

United kingdomRichard hughesDavid buddAlastair smithChris hollowoodSimon russellMahmud kamaniParsley box groupSyncona investment managementDigital envoy incLocation sciences groupSyncona limitedAvacta groupCaspian sunriseDepartment of healthJohn lewis partnership

Parsley Box Group PLC falls again on cash raising plans

A look at the major movers on the London market on Wednesday

United kingdomRichard hughesDavid buddAlastair smithChris hollowoodSimon russellMahmud kamaniParsley box groupSyncona investment managementDigital envoy incLocation sciences groupSyncona limitedAvacta groupDepartment of healthJohn lewis partnershipWiltshire farm foods

Gyroscope Therapeutics to be acquired for up to $1 5 billion

Gyroscope Therapeutics to be acquired for up to $1.5 billion Sale generates IRR of 55% for Syncona 22 December 2021 Agreement reached for Gyroscope Therapeutics to be acquired by Novartis for up to $1.5 billion (£1.1 billion1) with an upfront cash payment of $800 million (£604 million) and.

United kingdomChris hollowoodSyncona investment managementSyncona ltdGyroscope therapeutics holdingsGyroscope therapeuticsChief investment officerSyncona investment management limited

vimarsana © 2020. All Rights Reserved.